Findings

What do systematic reviews say?

24 questions · 24 findings · 5 reviews · Gynaecological, Neuro-oncology and Orphan Cancer

No studies found 7 · 29.2%GRADE not reported 0 · 0%Very low 3 · 12.5%Low 3 · 12.5%Moderate 7 · 29.2%High 4 · 16.7%

Progression‐free 5‐year survival2 · women with stage I/II epithelial ovarian cancer

1 finding from 1 review

Adjuvant (post‐surgery) chemotherapy for early stage epithelial ovarian cancer 2015 · Cochrane Headline outcomes only
no estimate extracted
1170 participants
High

Overall 10‐year3 survival · women with stage I/II epithelial ovarian cancer

1 finding from 1 review

Adjuvant (post‐surgery) chemotherapy for early stage epithelial ovarian cancer 2015 · Cochrane Headline outcomes only
no estimate extracted
925 participants
High

Progression‐free 10‐year survival4 · women with stage I/II epithelial ovarian cancer

1 finding from 1 review

Adjuvant (post‐surgery) chemotherapy for early stage epithelial ovarian cancer 2015 · Cochrane Headline outcomes only
no estimate extracted
925 participants
High

Adverse events · women with stage I/II epithelial ovarian cancer

The review found no eligible studies for this question.

1 finding from 1 review

Adjuvant (post‐surgery) chemotherapy for early stage epithelial ovarian cancer 2015 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found